EYE

0.00%

18.0¢ nova eye medical limited

Nova Eye Medical (EYE) Discussion, page-1103

First 1103 Last

Share
Profile

Follow
discreet

206 Posts.

10

23/08/23

13:06

Post #: 69501287
Share

Originally posted by TheAnalyst007: ↑

Yeah basically the MACs (the organisations responsible for implementing LCDs) are going through a process to revise the current LCD. They have proposed a new LCD that removes coverage for our procedure, but it is unlikely to be implemented given they fail to consider a substantial amount of evidence, and considering the considerable backlash they've received.

As a precedent example, the MACs attempted to implement an LCD back in 2020 to remove coverage for canaloplasty but that also received significant backlash, and was subsequently retired. Even if the LCD is implemented though, there is an appeals process (which another ASX company, PEB, has been successful in undertaking)

Regardless of the low probability of this LCD actually impacting EYE's financials, it will certainly continue to act as a drag on the share price. On the other hand, there's now a high probability catalyst for a rerate if/when we get the news that the LCD has been dropped

Expand

Thank you for explaining, can now better understand the discussions,

Originally posted by TheAnalyst007: ↑

Yeah basically the MACs (the organisations responsible for implementing LCDs) are going through a process to revise the current LCD. They have proposed a new LCD that removes coverage for our procedure, but it is unlikely to be implemented given they fail to consider a substantial amount of evidence, and considering the considerable backlash they've received.

As a precedent example, the MACs attempted to implement an LCD back in 2020 to remove coverage for canaloplasty but that also received significant backlash, and was subsequently retired. Even if the LCD is implemented though, there is an appeals process (which another ASX company, PEB, has been successful in undertaking)

Regardless of the low probability of this LCD actually impacting EYE's financials, it will certainly continue to act as a drag on the share price. On the other hand, there's now a high probability catalyst for a rerate if/when we get the news that the LCD has been dropped

Expand

EYE Price at posting: 23.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 2,085 more messages in this thread...

First 1103 Last

Add EYE (ASX) to my watchlist

(20min delay)
Last 18.0¢		Change 0.000(0.00%)		Mkt cap ! $41.23M

Open	High	Low	Value	Volume
19.0¢	19.0¢	18.0¢	$24.11K	132.1K

Buyers (Bids)

No.	Vol.	Price($)
4	137086	17.5¢

Sellers (Offers)

Price($)	Vol.	No.
18.5¢	30000	1

View Market Depth

No.	Vol.	Price($)
2	70000	0.175
5	102280	0.170
4	114241	0.165
9	297300	0.160
1	10000	0.155

Price($)	Vol.	No.
0.185	30000	1
0.190	120204	4
0.200	93423	2
0.205	15050	1
0.215	204291	4

Last trade - 14.41pm 04/10/2024 (20 minute delay)

EYE (ASX) Chart

Nova Eye Medical (EYE) Discussion, page-1103

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Nova Eye Medical (EYE) Discussion, page-1103

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News